These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11733620)

  • 1. Medullary nephrocalcinosis associated with long-term furosemide abuse in adults.
    Kim YG; Kim B; Kim MK; Chung SJ; Han HJ; Ryu JA; Lee YH; Lee KB; Lee JY; Huh W; Oh HY
    Nephrol Dial Transplant; 2001 Dec; 16(12):2303-9. PubMed ID: 11733620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nephrocalcinosis in full-term infants receiving furosemide treatment for congestive heart failure: a study of the incidence and 2-year follow up.
    Saarela T; Lanning P; Koivisto M; Paavilainen T
    Eur J Pediatr; 1999 Aug; 158(8):668-72. PubMed ID: 10445348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nephrocalcinosis in rabbits--correlation of ultrasound, computed tomography, pathology and renal function.
    Cramer B; Husa L; Pushpanathan C
    Pediatr Radiol; 1998 Jan; 28(1):9-13. PubMed ID: 9426266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sonographic diagnosis of furosemide-induced nephrocalcinosis in newborn infants.
    Pearse DM; Kaude JV; Williams JL; Bush D; Wright PG
    J Ultrasound Med; 1984 Dec; 3(12):553-6. PubMed ID: 6392586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visualization of renal medullary hyperattenuation at unenhanced CT: what is the effect of furosemide administration?
    Kumar R; Wang ZJ; Fu Y; Forsythe C; Webb EM; Yeh BM
    Radiology; 2010 May; 255(2):495-500. PubMed ID: 20413762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unsuspected medullary nephrocalcinosis from furosemide administration: sonographic evaluation.
    Reuter K; Kleinman PK; DeWitt T; Fabian T
    J Clin Ultrasound; 1985 Jun; 13(5):357-9. PubMed ID: 3924971
    [No Abstract]   [Full Text] [Related]  

  • 7. Nephrocalcinosis induced by long-term therapy with furosemide.
    Solivetti FM; Paganelli C; Zoffoli M; Bacaro D; Quintigliano D; Nasrollah N
    J Clin Ultrasound; 1997; 25(9):519-20. PubMed ID: 9350576
    [No Abstract]   [Full Text] [Related]  

  • 8. Exposure to furosemide as the strongest risk factor for nephrocalcinosis in preterm infants.
    Gimpel C; Krause A; Franck P; Krueger M; von Schnakenburg C
    Pediatr Int; 2010 Feb; 52(1):51-6. PubMed ID: 19460127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Echogenic renal pyramids in children.
    Jequier S; Kaplan BS
    J Clin Ultrasound; 1991 Feb; 19(2):85-92. PubMed ID: 1847953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resolution of medullary nephrocalcinosis in children with metabolic bone disorders.
    Auron A; Alon US
    Pediatr Nephrol; 2005 Aug; 20(8):1143-5. PubMed ID: 15973529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medullary nephrocalcinosis and pancreatic calcifications demonstrated by ultrasound and CT in infants after treatment with ACTH.
    Rausch HP; Hanefeld F; Kaufmann HJ
    Radiology; 1984 Oct; 153(1):105-7. PubMed ID: 6089261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperechoic renal medullary pyramids in infants and children.
    Shultz PK; Strife JL; Strife CF; McDaniel JD
    Radiology; 1991 Oct; 181(1):163-7. PubMed ID: 1887027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal calculi complicating short-term furosemide therapy after congenital heart surgery.
    Ali SK
    Congenit Heart Dis; 2006 Sep; 1(5):251-3. PubMed ID: 18377534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperechoic renal medullary pyramids in infants and children.
    Hernanz-Schulman M
    Radiology; 1991 Oct; 181(1):9-11. PubMed ID: 1887061
    [No Abstract]   [Full Text] [Related]  

  • 15. Furosemide-associated nephrocalcinosis and renal cysts.
    Uzu T; Araki S; Isshiki K; Maegawa H
    Kidney Int; 2011 Sep; 80(5):556. PubMed ID: 21841841
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of thiazide on established furosemide-induced nephrocalcinosis in the young rat.
    Knoll S; Alon US
    Pediatr Nephrol; 2000 Jan; 14(1):32-5. PubMed ID: 10654327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nephrocalcinosis in childhood. Sonographic findings and differential diagnosis].
    Gückel C; Benz-Bohm G; Roth B
    Rofo; 1989 Sep; 151(3):301-5. PubMed ID: 2552522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephrocalcinosis induced by furosemide in an adult patient with incomplete renal tubular acidosis.
    Simões A; Domingos F; Prata MM
    Nephrol Dial Transplant; 2001 May; 16(5):1073-4. PubMed ID: 11328921
    [No Abstract]   [Full Text] [Related]  

  • 20. Ultrasound diagnosis of renal calcification in infants on chronic furosemide therapy.
    Myracle MR; McGahan JP; Goetzman BW; Adelman RD
    J Clin Ultrasound; 1986 May; 14(4):281-7. PubMed ID: 3084585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.